Statins are one of the lipid lowering drugs that help in reducing cholesterol levels in the body by specifically inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase; which is a rate limiting enzyme for cholesterol synthesis. Rosuvastatin (RSV) and atorvastatin (ATV) have shown to have bone stimulatory and anti-inflammatory effects.. The present study aims to explore the efficacy of 1.2% RSV and 1.2% ATV gel as a local drug delivery and redelivery system as an adjunct to scaling and root planing (SRP) for the treatment of degree II furcation defects.
Statins are one of the lipid lowering drugs that help in reducing cholesterol levels in the body by specifically inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase; which is a rate limiting enzyme for cholesterol synthesis. Rosuvastatin (RSV) and atorvastatin (ATV) have shown to have bone stimulatory and anti-inflammatory effects.. The present study aims to explore the efficacy of 1.2% RSV and 1.2% ATV gel as a local drug delivery and redelivery system as an adjunct to scaling and root planing (SRP) for the treatment of degree II furcation defects. Methods: Ninety patients with mandibular buccal class II furcation defects were randomly allocated into three treatment groups: SRP plus placebo gel (group 1), SRP plus 1.2% RSV gel (group 2) and 1.2% ATV gel (group3). Clinical and radiographic parameters were recorded at baseline then after 6 months. The gels were redelivered at the respective sites at this 6 month appointment. Then again all clinical and radiographic parameters were recorded after 3 months. (9 months from baseline)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
90
Oral prophylaxis followed by placement of placebo gel
Oral prophylaxis followed by placement of rosuvastatin gel
Oral prophylaxis followed by placement of atorvastatin gel
Government Dental College and Research Institute
Bangalore, Karnataka, India
Change in Bone defect fill
Assessed in percentage
Time frame: baseline, 6 & 9 months
Change in modified sulcus bleeding index
scale 0-3
Time frame: baseline, 6 & 9 months
Change in Plaque index
scale 0-3
Time frame: baseline, 6 & 9 months
Change in pocket probing depth
measured in mm
Time frame: baseline, 6 & 9 months
Change in relative vertical clinical attachment level
measured in mm
Time frame: baseline, 6 & 9 months
Change in relative horizontal clinical attachment level
measured in mm
Time frame: baseline, 6 & 9 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.